Neuroreplacement therapy and stem cell biology under disease conditions

被引:46
作者
Sugaya, K [1 ]
机构
[1] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
关键词
stem cells; Alzheimer's disease; schizophrenia; transplantation; amyloid-beta precursor protein; reelin;
D O I
10.1007/s00018-002-3014-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent advances in stem cell technology are expanding our ability to replace a variety of cells throughout the body. In the past, neurological diseases caused by the degeneration of neuronal cells were considered incurable because of a long-held 'truism'; neurons do not regenerate during adulthood. However, this statement has been challenged, and we have now found much evidence that the brain is indeed capable of regenerating neurons after maturing. Based on this new concept, researchers have shown neural differentiation of stem cells and recovery of function following transplantation of these cells into the brain. These results may promise a bright future for clinical applications of stem cell strategies in neurological diseases; however, we must consider the pathophysiological environments of individual diseases that may affect stem cell biology. Before we begin to develop clinical applications, we must consider environmental factors that have not been discussed in the current preclinical studies. Here, we study cases of Alzheimer's disease and schizophrenia and discuss the effects of environmental factors under disease conditions.
引用
收藏
页码:1891 / 1902
页数:12
相关论文
共 122 条
[1]  
Alcántara S, 1998, J NEUROSCI, V18, P7779
[2]   Behavior of human neural progenitor cells transplanted to rat brain [J].
Aleksandrova, MA ;
Saburina, IN ;
Poltavtseva, RA ;
Revishchin, AV ;
Korochkin, LI ;
Sukhikh, GT .
DEVELOPMENTAL BRAIN RESEARCH, 2002, 134 (1-2) :143-148
[3]  
Alonso G, 1999, J COMP NEUROL, V405, P508, DOI 10.1002/(SICI)1096-9861(19990322)405:4<508::AID-CNE5>3.0.CO
[4]  
2-5
[5]  
AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO
[6]  
2-0
[7]  
Ando K, 1999, J NEUROSCI, V19, P4421
[8]   Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains [J].
Arai, Y ;
Suzuki, A ;
Mizuguchi, M ;
Takashima, S .
BRAIN & DEVELOPMENT, 1997, 19 (04) :290-294
[9]   Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study [J].
Bahn, S ;
Mimmack, M ;
Ryan, M ;
Caldwell, MA ;
Jaunlaux, E ;
Starkey, M ;
Svendsen, CN ;
Emson, P .
LANCET, 2002, 359 (9303) :310-315
[10]   Increased gene expression of beta-amyloid precursor protein and its homologues APLP1 and APLP2 in human neuroblastoma cells in response to retinoic acid [J].
Beckman, M ;
Iverfeldt, K .
NEUROSCIENCE LETTERS, 1997, 221 (2-3) :73-76